196 related articles for article (PubMed ID: 27482641)
21. Anti-Vascular Endothelial Growth Factor Therapy for Myopic Choroidal Neovascularization.
Ng DSC; Lai TYY; Cheung CMG; Ohno-Matsui K
Asia Pac J Ophthalmol (Phila); 2017; 6(6):554-560. PubMed ID: 29057641
[TBL] [Abstract][Full Text] [Related]
22. ASSESSING THE ACTIVITY OF MYOPIC CHOROIDAL NEOVASCULARIZATION: Comparison Between Optical Coherence Tomography Angiography and Dye Angiography.
Li S; Sun L; Zhao X; Huang S; Luo X; Zhang A; Chen C; Wang Z; Liu C; Ding X
Retina; 2020 Sep; 40(9):1757-1764. PubMed ID: 31652198
[TBL] [Abstract][Full Text] [Related]
23. Anti-VEGF therapy in myopic choroidal neovascularization: long-term results.
Freitas-da-Costa P; Pinheiro-Costa J; Carvalho B; Falcão M; Brandão E; Falcão-Reis F; Carneiro Â
Ophthalmologica; 2014; 232(1):57-63. PubMed ID: 24852069
[TBL] [Abstract][Full Text] [Related]
24. Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management.
Cheung CMG; Arnold JJ; Holz FG; Park KH; Lai TYY; Larsen M; Mitchell P; Ohno-Matsui K; Chen SJ; Wolf S; Wong TY
Ophthalmology; 2017 Nov; 124(11):1690-1711. PubMed ID: 28655539
[TBL] [Abstract][Full Text] [Related]
25. Retinal pigmental epithelium elevation and external limiting membrane interruption in myopic choroidal neovascularization: correlation with activity.
Ding X; Zhan Z; Sun L; Yang Y; Li S; Zhang A; Luo X; Lu L
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1831-1837. PubMed ID: 29982899
[TBL] [Abstract][Full Text] [Related]
26. Myopic choroidal neovascularization.
Ruiz-Moreno JM; López-Gálvez MI; Donate J; Gomez-Ulla F; García-Arumí J; García-Layana A; Sellés I; Reche J; Montero JA; Pazos B; Zapata MA; Pastor JC
Ophthalmology; 2011 Dec; 118(12):2521-3. PubMed ID: 22136676
[No Abstract] [Full Text] [Related]
27. Optical coherence tomography biomarkers for myopic choroidal neovascularization treated with anti-vascular endothelial growth factor.
Lee DY; Wu PY; Sheu SJ
Kaohsiung J Med Sci; 2023 Jun; 39(6):637-643. PubMed ID: 36916244
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
[TBL] [Abstract][Full Text] [Related]
29. Polypoidal Choroidal Vasculopathy: Imaging by Indocyanine Green Angiography and En Face Optical Coherence Tomography.
Kokame GT; Hirai K; Yanagihara R
JAMA Ophthalmol; 2015 Nov; 133(11):e151886. PubMed ID: 26562513
[No Abstract] [Full Text] [Related]
30. Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia.
Cohen SY
Retina; 2009 Sep; 29(8):1062-6. PubMed ID: 19734760
[TBL] [Abstract][Full Text] [Related]
31. Progression of myopic maculopathy after treatment of choroidal neovascularization.
Farinha CL; Baltar AS; Nunes SG; Figueira JP; Pires IA; Cachulo ML; Silva RM
Ophthalmologica; 2014; 231(4):211-20. PubMed ID: 24662778
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal bevacizumab in myopic neovascular membranes: 24-month results.
Ruiz-Moreno JM; López-Gálvez MI; Montero Moreno JA; Pastor Jimeno JC
Ophthalmology; 2013 Jul; 120(7):1510-1.e1. PubMed ID: 23823510
[No Abstract] [Full Text] [Related]
33. Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization.
Parravano M; Ricci F; Oddone F; Missiroli F; De Felici C; Varano M
Retina; 2014 Oct; 34(10):2053-62. PubMed ID: 24946101
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.
Yang HS; Kim JG; Kim JT; Joe SG
Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429
[TBL] [Abstract][Full Text] [Related]
35. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization.
Ahn SJ; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Idiopathic Choroidal Neovascularization Using Fluorescein Angiography, Indocyanine Green Angiography, and Optical Coherence Tomography Angiography.
Kumar A; Vohra R; Agrawal S; Chawla R; Azad SV; Venkatesh P; Sharma A
Ophthalmic Surg Lasers Imaging Retina; 2018 Jul; 49(7):516-522. PubMed ID: 30021039
[TBL] [Abstract][Full Text] [Related]
38. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION.
Inoue M; Balaratnasingam C; Freund KB
Retina; 2015 Nov; 35(11):2265-74. PubMed ID: 26405770
[TBL] [Abstract][Full Text] [Related]
39. Sudden-Onset Unilateral Macular Hemorrhage in a Middle-aged Man.
Dahrouj M; Oellers P; Wu DM
JAMA Ophthalmol; 2018 Nov; 136(11):1301-1302. PubMed ID: 30177992
[No Abstract] [Full Text] [Related]
40. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Lee H; Ji B; Chung H; Kim HC
Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
